Europe Cell Therapy Market
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines. Increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies is likely to drive the growth of the Cell therapy market during the forecast period.
The Europe Cell therapy market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. Factors such as Increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies are expected to boost the growth of the Cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing in emerging countries during the forecast period.
COVID-19 pandemic has become the most significant challenge across the Europe region. The cell therapy instrument market witnessed some shortfall at the beginning of COVID-19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries. However, the demand for the cell therapy increased drastically owing to supportive government initiatives.
The scope of the Europe Cell therapy market includes therapy type, product, technology, application, end user and country. In terms of therapy types, in 2019, the allogeneic segment accounted for the highest share owing to the availability of substantial number of approved products for clinical use. However, the autologous segment is also likely to register the highest CAGR in the market during the forecast period.
Several major primary and secondary sources associated with the Europe Cell therapy market report are the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Alliance for Regenerative Medicine, National Institutes of Health, Anthony Nolan Foundation, among others.
The Europe Cell Therapy Market is valued at US$ 2,125.7 Million in 2019, it is projected to reach US$ 3,610.7 Million by 2027.
As per our report Europe Cell Therapy Market, the market size is valued at US$ 2,125.7 Million in 2019, projecting it to reach US$ 3,610.7 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cell Therapy Market report:
The Europe Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Cell Therapy Market
